Pharmacoeconomic analysis
Pharmacoeconomic analysis brings resource use into the assessment of pharmaceutical care. A management analysis of expenditure or availability is not, on its own, proof of clinical effectiveness.
Ihor Hayduchok's 2021 study applies ABC/VEN analysis to antiviral medicines considered in the context of psoriasis with antiphospholipid syndrome. It combines regulatory, documentary, marketing and pharmacoeconomic investigation, including examination of the assortment, dosage forms, registration information and manufacturers' countries. The combined matrix is presented as a basis for administrative and managerial decisions.
The useful conceptual lesson is the need to connect medicine selection with both the characteristics of the products and the constraints of the care system. The article should be read as a particular research application, not as a treatment protocol or a recommendation that antiviral medicines are appropriate for every patient with psoriasis. Related topics: access to medicines, pharmaceutical management and evidence appraisal.
Source
Hayduchok, I. (2021). Pharmacotherapy of Psoriasis Support with Antiphospholipid Syndrome: ABC/VEN Analysis of Anti-Viral Drugs. SSP Modern Pharmacy and Medicine, 1(1), 1–12.
See also: Terms and concepts index · Journal research map · History and research foundations.